Absci Corporation
NASDAQAbsci Corporation reported Q2 earnings on August 11 into a week that combined a sharp short interest rebuild, a 11% price gain, and uniform analyst reaffirmation — a tension between rising bearish positioning and bullish price action that defines the setup heading into the post-print period. Short interest is the clearest story this week, and it tells a cautionary tale. Shorts…
Snapshot as of 23 Sept 2026
Absci Corporation reported Q2 earnings on August 11 into a week that combined a sharp short interest rebuild, a 11% price gain, and uniform analyst reaffirmation — a tension between rising bearish positioning and…
ABSI has ripped 56% in a single week to $11.59, yet the shorts have barely moved — setting up one of the more telling standoffs in small-cap biotech right now. The short position is stubbornly large. Short interest…
ABSI heads into the final days of June with a jarring contradiction: the stock fell nearly 12% on Tuesday while the Street is busily raising price targets to levels well above the current price. The analyst tone has…
Absci Corporation heads into its June 4 earnings report with short sellers in measured retreat and an analyst upgrade providing fresh upside context — while options traders turned their most call-heavy in months. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABSI — free to start on ORTEX.
Sign up for free →Open ABSI on ORTEX